Qin Yan

13.7k citations

229 papers · 9.0k indexed · 3 hit papers · h-index 51

Impact in

Cancer Research top 0.5%
- Cancer-related molecular mechanisms research
- Cancer, Hypoxia, and Metabolism
Molecular Biology top 1%
- Epigenetics and DNA Methylation
- RNA modifications and cancer
- Cancer-related gene regulation
- Ubiquitin and proteasome pathways
- Histone Deacetylase Inhibitors Research

Papers in

Molecular Biology 151
- Epigenetics and DNA Methylation 45
- RNA modifications and cancer 26
- Histone Deacetylase Inhibitors Research 20
- Cancer-related gene regulation 20
- Advanced biosensing and bioanalysis techniques 19
- Natural product bioactivities and synthesis 15
- RNA Interference and Gene Delivery 13
- Ubiquitin and proteasome pathways 12
Cancer Research 24

Co-authors: Jian Cao William G. Kaelin Joan Conaway Ronald Conaway Takumi Kamura Philip E. Branton Mike R. Zou Emmanuelle Querido
Journals: Journal of Biological Chemistry (7 papers)Cancer Research (6 papers)Cold Spring Harbor Protocols (6 papers)Ore Geology Reviews (6 papers)Scientific Reports (4 papers)
Partner nations: China United States Canada

In The Last Decade

Qin Yan

214 papers receiving 8.9k citations

Hit Papers

align trajectories log scale

Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA 2019 · 429 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2019 Cell Death and Differentiation
2007 Cell
2001 Genes & Development

Peers

Countries citing papers authored by Qin Yan

Since Specialization

Citations

This map shows the geographic impact of Qin Yan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Qin Yan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Qin Yan more than expected).

Fields of papers citing papers by Qin Yan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Qin Yan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Qin Yan. The network helps show where Qin Yan may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Qin Yan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Qin Yan Line = papers co-authored together Qin Yan links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SUV39H1 Regulates KLF4 and Chromatin Remodeling in Smooth Muscle Cell Phenotypic Plasticity Arteriosclerosis Thrombosis and Vascular Biology ·赵峰远, В. Г. Тимофеев, Qin Yang, CATH HAYES, Peng Xu, 武志舟山, Yi Xie, Qin Yan, John Hwa, Kathleen A. Martin	2025	0
2	Plasma exchange as an effective treatment for cytokine release syndrome following T cell receptor‑engineered T cell immunotherapy: A case report Oncology Letters ·Xixi Zheng, Shuo Zhang, Robert E. Eckardt, Don E. Walicek, Ke Zheng, Ying Wang, Qin Yan	2024	1
3	Gamabufotalin loaded micro-nanocomposites for multimodal therapy of metastatic TNBC by efficiently inducing ICD Biomaterials ·Jialong Fan, Qin Yan, Wensheng Qiu, Jiahao Liang, Chang Xiao, Qian Xie, Chunyi Tong, Liqin Yuan, Ying Long, 吴秀香	2024	7
4	MYD88L265P augments proximal B-cell receptor signaling in large B-cell lymphomas via an interaction with DOCK8 Blood ·Elisa Mandato, Qingsheng Yan, Jing Ouyang, S.K. Pandey S.V. Singh and Dinesh Kumar P. Manivel, Qin Yan, Yansheng Hao, Kamil Bojarczuk, Wei-Feng Ding, Bjoern Chapuy, Scott J. Rodig, Théophane Piette, Robert Redd, Margaret A. Shipp	2023	3
5	Loss of LRRC33-Dependent TGFβ1 Activation Enhances Antitumor Immunity and Checkpoint Blockade Therapy Cancer Immunology Research ·Aiping Jiang, Qin Yan, Timothy A. Springer	2022	8
6	Human WDR5 promotes breast cancer growth and metastasis via KMT2-independent translation regulation eLife ·Wesley L. Cai, A.K. Tashkenbayeva, Huacui Chen, А. А. Балдаев, Sarah J. Kurley, Lok-Hei Chan, Meiling Zhang, Anna Arnal Estape, Minghui Zhao, Glenda Maria Braga Abud, Wenxue Li, Xufen Yu, Nikolaidis Stefanos, Yali Dou, Yansheng Liu, Jian Jin, Thomas F. Westbrook, Don X. Nguyen, Qin Yan	2022	14
7	The Crossroads of Cancer Epigenetics and Immune Checkpoint Therapy Clinical Cancer Research ·Goran Micevic, Marcus Bosenberg, Qin Yan	2022	40
8	The roles of epigenetics in cancer progression and metastasis Biochemical Journal ·Matteo Mazza, Qin Yan	2021	51
9	PPARα Inhibition Overcomes Tumor-Derived Exosomal Lipid-Induced Dendritic Cell Dysfunction Cell Reports ·Xiaozhe Yin, Wenfeng Zeng, Bowen Wu, Luoyang Wang, Zihao Wang, Hongjian Tian, Luyao Wang, U Neumann, Ryan Clay, Xiuli Wei, Qin Yan, Fayun Zhang, Chunling Zhang, Lingtao Jin, Wei Liang	2020	131
10	Annotation and cluster analysis of long noncoding RNA linked to male sex and estrogen in cancers npj Precision Oncology ·Shouping Liu, Weiwei Lai, Ying Shi, Na Liu, Lianlian Ouyang, Ziying Zhang, Ling Chen, Xiang Wang, Krzysztof Więcek, Desheng Xiao, Qin Yan, Ya Cao, Shuang Liu, Yongguang Tao	2020	13
11	Multi-Omics Investigation of Innate Navitoclax Resistance in Triple-Negative Breast Cancer Cells Cancers ·Michał Marczyk, Gauri A. Patwardhan, Jun Zhao, Rihao Qu, Xiaotong Li, Vikram B. Wali, Abhishek Gupta, Manoj M. Pillai, Yuval Kluger, Qin Yan, Christos Hatzis, Lajos Pusztai, Vignesh Gunasekharan	2020	15
12	Cancer progression is mediated by proline catabolism in non-small cell lung cancer Oncogene ·Yating Liu, Chao Mao, Min Wang, Na Liu, Lianlian Ouyang, Shouping Liu, Haosheng Tang, Ya Cao, Shuang Liu, Xiang Wang, Desheng Xiao, Ceshi Chen, Ying Shi, Qin Yan, Yongguang Tao	2020	60
13	Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction Nature Communications ·Mingzhu Yin, Ying Guo, Rui Hu, Wesley L. Cai, Yao Li, Shiyao Pei, Hongyin Sun, Cong Peng, Jiali Li, Rui Ye, Qiaohong Yang, Jaime Vinicio Guzmán Potosi, Yongguang Tao, Xiang Chen, Qin Yan	2020	115
14	PBRM1 acts as a p53 lysine-acetylation reader to suppress renal tumor growth Nature Communications ·Weijia Cai, Liya Su, Lili Liao, Zongzhi Liu, إیمان أحمد محمد علی أبو النور, Essel Dulaimi, Joseph R. Testa, Robert G. Uzzo, Zhijiu Zhong, Wei Jiang, Qin Yan, Qing Zhang, Haifeng Yang	2019	55
15	Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA Cell Death and Differentiation ·Min Wang, Chao Mao, Lianlian Ouyang, Yating Liu, Weiwei Lai, Na Liu, Ying Shi, Ling Chen, Desheng Xiao, Fenglei Yu, Xiang Wang, Hu Zhou, Ya Cao, Shuang Liu, Qin Yan, Yongguang Tao, Bin Zhang Hit paper breakdown →	2019	429
16	Identification and Validation of a Novel Biologics Target in Triple Negative Breast Cancer Scientific Reports ·Vikram B. Wali, Gauri A. Patwardhan, Vasiliki Pelekanou, Thomas Karn, Jian Cao, Alberto Ocaña, Qin Yan, Bryce Nelson, Christos Hatzis, Lajos Pusztai	2019	18
17	Cell Division Cycle 42 plays a Cell type-Specific role in Lung Tumorigenesis Scientific Reports ·Chao Zheng, Yuetong Wang, Yang Liu, Shuhua Zhou, Yijun Gao, Fuming Li, Yan Feng, Zuoyun Wang, Lixing Zhan, Qin Yan, Xueliang Zhu, Kwok‐Kin Wong, Zhengjun Chen, Hongbin Ji	2017	9
18	Coordinating antigen cytosolic delivery and danger signaling to program potent cross-priming by micelle-based nanovaccine Cell Discovery ·Zhida Liu, 璐华, Qin Yan, Zihao Wang, 杉本学, Xiuli Wei, Pierre Noreau, Qicheng Li, Hang Zhou, Wenjun Wang, Yang-Xin Fu, Mingzhao Zhu, Wei Liang	2017	45
19	KDM5 lysine demethylases are involved in maintenance of 3′UTR length Science Advances ·Lauren P. Blair, Zongzhi Liu, Ramon Lorenzo D. Labitigan, Lizhen Wu, Dinghai Zheng, Zheng Xia, H. CHO, Andrew Crossen, Jian Cao, Sabine M. Lang, Stéphanie Guernon, Samuel G. Mackintosh, Claire Moore, Wei Li, Bin Tian, Alan J. Tackett, Qin Yan	2016	27
20	Histone Demethylase RBP2 Promotes Lung Tumorigenesis and Cancer Metastasis Cancer Research ·Yu‐Ching Teng, Cheng-Feng Lee, Ying-Shiuan Li, Yiren Chen, Pei‐Wen Hsiao, Catherine L Kempster, Feng‐Mao Lin, Hsien‐Da Huang, Yen-Ting Chen, Yung‐Ming Jeng, Chih-Hung Hsu, Qin Yan, Ming‐Daw Tsai, Li‐Jung Juan	2013	119

About Qin Yan

Qin Yan is a scholar working on Molecular Biology, Cancer Research, Geochemistry and Petrology, Immunology and Oncology, having authored 229 papers that have together received 9.0k indexed citations. Recurring topics across this work include Epigenetics and DNA Methylation (45 papers), RNA modifications and cancer (26 papers), Histone Deacetylase Inhibitors Research (20 papers), Cancer-related gene regulation (20 papers), Advanced biosensing and bioanalysis techniques (19 papers), Natural product bioactivities and synthesis (15 papers), RNA Interference and Gene Delivery (13 papers) and Ubiquitin and proteasome pathways (12 papers). The work is most often cited by research in Cancer Research (1.8k citations), Molecular Biology (5.9k citations), Oncology (1.4k citations), Immunology (922 citations) and Rehabilitation (259 citations). Qin Yan has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Jian Cao, William G. Kaelin, Joan Conaway, Ronald Conaway, Takumi Kamura, Philip E. Branton, Mike R. Zou, Emmanuelle Querido, Yongguang Tao and Paola Blanchette. Their work appears in journals such as Journal of Biological Chemistry, Cancer Research, Cold Spring Harbor Protocols, Ore Geology Reviews and Scientific Reports.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact